Medinet: Summary of Financial Results for the first quarter 2025

Feb 13 01:30 ET

Medinet: Notice regarding the recording of non-operating income

Feb 13 01:30 ET

Medinet: Notice regarding the death of an auditor and the appointment of an alternate auditor as an auditor

Jan 31 01:30 ET

Medinet: Independent Officer Registration Form

Jan 24 04:30 ET

Medinet: Notice regarding the recording of special profit (profit from sale of investment securities)

Jan 5 23:15 ET

Medinet: Notice Concerning Election of Director Candidates and Audit & Supervisory Board Candidates

Nov 22, 2024 01:30 ET

Medinet: Notice Concerning Decrease in Capital and Capital Reserve Amounts and Disposal of Surplus Funds

Nov 22, 2024 01:30 ET

Medinet: Notice regarding the recording of non-operating income and extraordinary losses

Nov 13, 2024 01:30 ET

Medinet: Summary of Financial Results 2024

Nov 13, 2024 01:30 ET

Medinet: Explanatory materials on business plans and growth potential

Nov 13, 2024 01:30 ET

Medinet: [Progress of disclosure matters] Decision to discontinue development of regenerative medicine products for the purpose of treating chronic heart failure

Nov 8, 2024 01:30 ET

Medinet: Notice regarding mass exercise and completion of exercise of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment

Sep 11, 2024 03:00 ET

Medinet: Strategic partnership agreement signed with AGC for cell therapy CDMO business

Sep 10, 2024 22:00 ET

Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment

Sep 2, 2024 02:00 ET

Medinet: Announcements of individual stocks regarding the recognition of non-operating revenue.

Aug 9, 2024 02:00 ET

Medinet: Overview of Q3 2024 financial results.

Aug 9, 2024 02:00 ET

Medinet: Started manufacturing outsourcing for a new specified cell processed product ("S-DSC") related to hair regeneration.

Aug 8, 2024 02:00 ET

Medinet: (Progress of disclosure matters) Taiwanese regulatory authorities have approved the provision of γδT cell therapy at new medical institutions (progress of licensing agreement with Medigen Biotechnology Corp.)

Jul 8, 2024 02:00 ET

Medinet: Notice Concerning the Recording of Non-Operating Income and Non-Operating Expenses

May 10, 2024 02:00 ET

Medinet: Summary of financial results for the 2nd quarter of 2024

May 10, 2024 02:00 ET